Main Page Side Effects Insurance Coverage Review Board

Mounjaro Constipation Crisis — Last Resort Options

Action Plan When Mounjaro Constipation Is Severe

You’ve tried MiraLAX. It’s been 5, 6, or 7+ days. You’re in pain. Let’s address this now.

Step 1: Assess for Red Flags

Seek emergency care if:

  • Nausea with vomiting and no BM
  • Severe, localized abdominal pain
  • Belly is hard as a board
  • Fever
  • Rectal bleeding

These are signs of a medical emergency.

The Last-Resort Stack

If no red flags:

Right Now: Insert a Dulcolax suppository — fastest OTC method. This creates local stimulation.

When the suppository doesn’t work: Add oral stimulant laxative. Give it overnight.

Also right now: Drink 32 oz of water — hydration helps everything work.

30 minutes later: Double the normal MiraLAX dose — one-time double dosing is acceptable.

Next morning if still stuck: Mag07 5 capsules on empty stomach + more fluid.

Step 3: If OTC Still Fails

When the rescue sequence doesn’t produce results shows no improvement:

  • Contact your provider — available options include:

    • Lactulose
    • Enemas — fast-acting
    • If fecal impaction has occurred — must be done by a healthcare provider
  • Consider dose reduction — this level of Mounjaro may be overly suppressing motility

Never Let It Get This Bad Again

Once you’ve resolved this episode:

Daily non-negotiables:

  1. MiraLAX 17g daily — don’t skip
  2. 80-100+ oz water
  3. Daily fiber — never dry
  4. Post-meal walk

If you notice slowing:

  • Don’t wait — use a rescue product at the first sign of backup, not after a full week

What this episode teaches: early intervention prevents emergencies. Stay ahead of constipation on Mounjaro.

References

  1. FDA Prescribing Information for GLP-1 receptor agonists. U.S. Food and Drug Administration. 2024.
  2. SURPASS and SURMOUNT clinical trial programs. Eli Lilly and Company. 2022-2025.
  3. SUSTAIN and STEP clinical trial programs. Novo Nordisk. 2017-2024.
  4. American Diabetes Association Standards of Care in Diabetes. 2025.
  5. American Society of Health-System Pharmacists (ASHP) Drug Information. 2025.